Knotek Ondrej is an MEP (Renew Europe) co-chair of the TRANSFORM MEP Interest Group which aims at promoting dialogue on transformative gene and cell therapies, as well as a member of the Committee on the Environment, Public Health and Food Safety (ENVI). Previously, he worked as quality manager at ROTAREX, a Czech pharmaceutical company, where he implemented EU legislation on medical products such as the Medical Device Regulation (MDR). Knotek holds degrees from the Czech Technical University and the Institute of Chemical Technology, both located in Prague. In addition to his committee assignments, Knotek is part of the Parliament’s delegation to the EU-Montenegro Stabilisation and Association Parliamentary Committee.